ES2053095T3 - Derivados heterociclicos. - Google Patents

Derivados heterociclicos.

Info

Publication number
ES2053095T3
ES2053095T3 ES90300780T ES90300780T ES2053095T3 ES 2053095 T3 ES2053095 T3 ES 2053095T3 ES 90300780 T ES90300780 T ES 90300780T ES 90300780 T ES90300780 T ES 90300780T ES 2053095 T3 ES2053095 T3 ES 2053095T3
Authority
ES
Spain
Prior art keywords
optionally
thiazole
replaced
alkynyl
atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90300780T
Other languages
English (en)
Spanish (es)
Inventor
Graham Charles Crawley
Martin Paul Edwards
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca SAS
Imperial Chemical Industries Ltd
Original Assignee
ICI Pharma SA
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ICI Pharma SA, Imperial Chemical Industries Ltd filed Critical ICI Pharma SA
Application granted granted Critical
Publication of ES2053095T3 publication Critical patent/ES2053095T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES90300780T 1989-01-30 1990-01-25 Derivados heterociclicos. Expired - Lifetime ES2053095T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89400251 1989-01-30

Publications (1)

Publication Number Publication Date
ES2053095T3 true ES2053095T3 (es) 1994-07-16

Family

ID=8202915

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90300780T Expired - Lifetime ES2053095T3 (es) 1989-01-30 1990-01-25 Derivados heterociclicos.

Country Status (13)

Country Link
US (2) US5089495A (enExample)
EP (1) EP0381375B1 (enExample)
JP (1) JPH03197471A (enExample)
AT (1) ATE82286T1 (enExample)
AU (1) AU626977B2 (enExample)
CA (1) CA2007654A1 (enExample)
DE (1) DE69000438T2 (enExample)
DK (1) DK0381375T3 (enExample)
ES (1) ES2053095T3 (enExample)
GR (1) GR3006324T3 (enExample)
IE (1) IE62558B1 (enExample)
NZ (1) NZ232094A (enExample)
ZA (1) ZA90264B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196422A (en) * 1988-07-12 1993-03-23 Ici Pharma 5-lipoxygenase inhibiting thiazoles
US5254581A (en) * 1990-06-21 1993-10-19 Imperial Chemical Industries Plc Pyran derivatives and their use as inhibitors of 5-lipoxygenase
IE914005A1 (en) * 1990-12-14 1992-06-17 Zeneca Ltd Novel intermediates
DE4139751A1 (de) * 1991-12-03 1993-06-09 Bayer Ag, 5090 Leverkusen, De Thiazolyl substituierte chinolylmethoxyphenylessigsaeurederivate
US5281720A (en) * 1991-02-28 1994-01-25 Merck Frosst Canada, Inc. Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis
GB9122590D0 (en) * 1991-10-24 1991-12-04 Lilly Industries Ltd Pharmaceutical compounds
ES2163407T3 (es) * 1992-02-13 2002-02-01 Merrell Pharma Inc Derivados piperidinilos tiaciclicos.
US5308852A (en) * 1992-06-29 1994-05-03 Merck Frosst Canada, Inc. Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
US5252599A (en) * 1992-08-27 1993-10-12 Merck Frosst Canada, Inc. Heteroarylnaphthalene hydroxy acids as inhibitors of leukotriene biosynthesis
US5426109A (en) * 1992-08-27 1995-06-20 Merck Frosst Canada, Inc. Phenylnaphthalene hydroxy acids
US5428060A (en) * 1992-08-27 1995-06-27 Merck Frosst Canada, Inc. Heteroarylnaphthalene lactones as inhibitors of leukotriene biosynthesis
US5350744A (en) * 1992-08-27 1994-09-27 Merck Frosst Canada, Inc. Phenylnaphthalene lactones as inhibitors of leukotriene biosynthesis
EP0632027A1 (de) * 1993-07-01 1995-01-04 BASF Aktiengesellschaft 6-(Carbonyloxymethylene)-Chinoline
DE4411657A1 (de) * 1994-04-02 1995-10-05 Basf Ag Verfahren zur Herstellung von 6-Hydroxymethylchinolinen
US5552437A (en) * 1994-10-27 1996-09-03 Merck Frosst Canada, Inc. Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis
US5527827A (en) * 1994-10-27 1996-06-18 Merck Frosst Canada, Inc. Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis
CA2422675A1 (en) * 2000-10-03 2002-04-11 Syngenta Participations Ag Phenylpropynyloxypyridine herbicides
US6548670B1 (en) 2001-07-19 2003-04-15 Air Products And Chemicals, Inc. Methods for preparing 5- and 6-benzyl-functionalized quinoxalines
US6825221B2 (en) 2001-10-18 2004-11-30 Allergan, Inc. Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56702B1 (en) * 1982-12-01 1991-11-06 Usv Pharma Corp Antiinflammatory antiallergic compounds
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
US4721721A (en) * 1984-12-18 1988-01-26 Rorer Pharmaceutical Corporation 6-(4-thiazole) compounds, cardiotonic compositions including the same, and their uses
US4839369A (en) * 1985-04-16 1989-06-13 Rorer Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4876346A (en) * 1985-05-02 1989-10-24 American Home Products Corporation Quinoline compounds
US4661499A (en) * 1985-06-18 1987-04-28 Merck Frosst Canada, Inc. 2-[(substituted)-phenoxymethyl]quinolines
JPS62142168A (ja) * 1985-10-16 1987-06-25 Mitsubishi Chem Ind Ltd チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤
DE3783105T2 (de) * 1986-03-13 1993-04-22 Rhone Poulenc Rorer Int Chinolinylaether tetrazole als mittel zur behandlung von hyperempfindlichen krankheiten.
GB8820389D0 (en) * 1988-08-26 1988-09-28 Beecham Group Plc Novel compounds
IL93343A0 (en) * 1989-02-28 1990-11-29 Ici Plc Heterocyclic cycloalkanes
IL93344A0 (en) * 1989-02-28 1990-11-29 Ici Plc Heterocyclic cyclic ethers

Also Published As

Publication number Publication date
ZA90264B (en) 1990-10-31
EP0381375B1 (en) 1992-11-11
CA2007654A1 (en) 1990-07-30
AU626977B2 (en) 1992-08-13
IE900144L (en) 1990-07-30
DE69000438T2 (de) 1993-03-25
JPH03197471A (ja) 1991-08-28
AU4859690A (en) 1990-08-02
US5089495A (en) 1992-02-18
GR3006324T3 (enExample) 1993-06-21
DK0381375T3 (da) 1993-01-25
IE62558B1 (en) 1995-02-08
DE69000438D1 (de) 1992-12-17
ATE82286T1 (de) 1992-11-15
NZ232094A (en) 1992-06-25
US5283245A (en) 1994-02-01
EP0381375A1 (en) 1990-08-08

Similar Documents

Publication Publication Date Title
ES2053095T3 (es) Derivados heterociclicos.
WO1993000095A3 (en) Bicyclic fibrinogen antagonists
FI882081A7 (fi) 2-substituerade e-fusionerade (1,2,4) triazolo(1,5-c) pyrimidiner, farmaceutiska kompositioner och deras anvaendning.
IL99926A0 (en) Cyclo imino derivatives,their preparation and pharmaceutical compositions containing them
DE10199003I1 (de) Substituierte Thiazolidinionderivate
IL101836A (en) Pharmaceutical compositions containing 1, 3-oxathiolane nucleoside analogues
ES2150903T3 (es) Derivados de 2-aralcoxi y 2-alcoxi adenosina de utilidad como vasodilatadores coronarios y como agentes antihipertensivos.
ZA906709B (en) Thiazolidinedione derivatives
DK346089A (da) Heterocykliske forbindelser
RU99101864A (ru) Новое производное тиофена и содержащая его фармацевтическая композиция
CO5130006A1 (es) Compuestos de pirazina
ATE22530T1 (de) Durch saeure stabilisierte mischungen von thienopyridinderivaten und verfahren zum verhindern der zersetzung solcher verbindungen.
ES2056383T3 (es) Eteres ciclicos de diarileter.
HUT61009A (en) Process for producing 1,4-dihydropyridine derivatives and pharmaceutical compositions comprising same as active ingredient
GR3004729T3 (enExample)
DK0412058T3 (da) 1-Acyl-2-pyrrolidinoner som indlærings- og hukommelsesforstærkende midler og farmaceutiske præparater indeholdende disse forbindelser
MX9301721A (es) Derivados, composiciones de carbinol de bis-arilo sin puente, y metodos de uso.
DE68927554D1 (de) Cephalosporinverbindungen und Verfahren zu ihrer Herstellung
IL71503A (en) 2,4-bis(allylamino)-6-(substituted cyclic polymethylenimino)-1,3,5-triazines,their preparation and pharmaceutical compositions containing them
NZ240404A (en) Oxysulphonyl (thio)carbamate derivatives and pharmaceutical
HUT61967A (en) Process for producing new alkyl aminoalkyl amine- and -ether derivatives and pharmaceutical compositions comprising such compounds
AR247737A1 (es) Un procedimiento para la fabricacion de compuestos.
ES2032838T3 (es) Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol.
ES2053880T3 (es) Utilizacion de derivados de adenosina en la preparacion de composiciones farmaceuticas que poseen actividad inmunoestimulante.
ES2053736T3 (es) Un procedimiento para la preparacion de un derivado de ergolina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 381375

Country of ref document: ES